1-5 of 5
Mariola Sadowska, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Synergistic Antileukemic Effect Of Sequential Administration Of Dichloroacetate (DCA) Combined With Arsenic Trioxide (ATO) In Primary Blasts From Patients With Acute Myeloid Leukemia (AML) and FLT3-ITD AML Cell Lines

Ashkan Emadi, M.D., Ph.D., Brandon Carter-Cooper, BS, Mariola Sadowska, PhD, Omasiri Wonodi, BS, Rena G. Lapidus, PhD, Mark Levis, MD, PhD, Edward A. Sausville, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3955.
https://doi.org/10.1182/blood.V122.21.3955.3955
Published: 2013
Journal Articles

Dimeric Naphthoquinones: Novel Anti-Leukemic Agents Modulating Cellular Redox Status

Ashkan Emadi, M.D., Ph.D., Mariola Sadowska, PhD, Brandon Carter-Cooper, BS, Omasiri Wonodi, BS, Nidal Muvarak, BS, Feyruz Rassool, PhD, Anil Jaiswal, PhD, Maria R. Baer, MD, Rena G. Lapidus, PhD, Edward A. Sausville, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1290.
https://doi.org/10.1182/blood.V122.21.1290.1290
Published: 2013
Journal Articles

A Pilot Study of Acupuncture in Treating Bortezomib-Induced Peripheral Neuropathy (BIPN) in Multiple Myeloma (MM) Patients.

Ting Bao, MD, Neil Porter, MD, James Primrose, RN, Olga Goloubeva, Lisa Hester, Lulu Wang, MS, Mariola Sadowska, PhD, Rena Lapidus, PhD, Michelle Medeiros, MS, MA, Lixing Lao, PhD, L.Ac., Susan Dorsey, RN, PhD, Ashraf Z. Badros, MD
Journal: Blood
Blood (2012) 120 (21): 3168.
https://doi.org/10.1182/blood.V120.21.3168.3168
Published: 2012
Journal Articles

Single Agent Activity of the Cyclin-Dependent Kinase (CDK) Inhibitor Dinaciclib (SCH 727965) In Acute Myeloid and Lymphoid Leukemia Cells

Mariola Sadowska, PhD, Nidal Muvarak, BS, Rena G. Lapidus, PhD, Edward A. Sausville, MD, PhD, Rajat Bannerji, MD, PhD, Ivana Gojo, MD
Journal: Blood
Blood (2010) 116 (21): 3981.
https://doi.org/10.1182/blood.V116.21.3981.3981
Published: 2010
Journal Articles

Phase II Study of the Cyclin-Dependent Kinase (CDK) Inhibitor Dinaciclib (SCH 727965) In Patients with Advanced Acute Leukemias

Ivana Gojo, MD, Alison Walker, MD, Maureen Cooper, MD, Eric J Feldman, MD, Swaminathan Padmanabhan, MBBS, MS, Maria R Baer, MD, Jennifer Poon, PharmD, Karen Small, BSN, Da Zhang, MS, Mariola Sadowska, PhD, Rajat Bannerji, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3287.
https://doi.org/10.1182/blood.V116.21.3287.3287
Published: 2010